Australia's EchoIQ heads for worst week in seven years after US FDA setback
11/09/2026 06:23
BUZZ-Australia's EchoIQ heads for worst week in seven years after US FDA setback ** Shares of EchoIQ EIQ.AX are on track for a nearly 62% weekly loss, their worst weekly performance in seven years
** In current session, stock falls as much as 15.8% to A$0.4800, extending losses for a third consecutive session
** On Tuesday, stock plunged as much as 63.3% after the AI-powered medical software company said the U.S. FDA did not clear its application to commercialise its tool designed to detect heart failure
** YTD stock up about 91%
(Reporting by Paridhi Minda in Bengaluru)
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt